Last updated on August 2019

Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus


Brief description of study

To evaluate the safety and tolerability of subcutaneous (SC) dose administrations of AMG 592 in subjects with systemic lupus erythematosus (SLE)

Clinical Study Identifier: NCT03451422

Find a site near you

Start Over

Research Site

Great Neck, NY United States
  Connect »

Research Site

Duncansville, PA United States
  Connect »

Research Site

Dallas, TX United States
  Connect »

Research Site

Lille cedex 01, France
  Connect »

Research Site

Strasbourg, France
  Connect »

Research Site

Warszawa, Poland
  Connect »

Research Site

Anniston, AL United States
  Connect »

Research Site

Beverly Hills, CA United States
  Connect »

Research Site

Marseille, France
  Connect »